Management Forum Logo

Presented by
Management Forum

Pharmacovigilance In-house Training

Understanding PhV today – a basic training course on the principles and practice of global PhV for those working in drug safety.

★★★★★ "All of the speakers were absolutely great, the talks were very interesting, informative and on a hig... more (37)"

Need help?  Customise

Course overview

This comprehensive three-day pharmacovigilance training course has been designed to provide an introductory guide for all those concerned with vigilance industry. The interactive programme will cover topics from basic pharmacovigilance principles and terminologies through to the current regulatory framework and its global impact, including drug surveillance in the EU, US and Japan. Proactive pharmacovigilance pre- and post-marketing will be addressed as will risk management, the challenges of causality assessments and effective signal detection.

Our panel of experts will offer practical guidance throughout the training course and use real-world examples and case studies to contribute to the development of your knowledge. There will also be ample opportunity to share experiences with the speakers and fellow professionals, which will further enhance your understanding of pharmacovigilance issues.

Key topics to be addressed include:

  • Principles of pharmacovigilance and data resources
  • Risk management, causality assessment and postauthorisation safety and efficacy studies (PASS/PAES)
  • Pharmacoepidemiological studies and evolution of periodic safety update reports (PSURs), periodic benefit-risk evaluation reports (PBRERs) and development safety update reports (DSURs)
  • Proactive pharmacovigilance pre- and post-marketing, risk-benefit assessment
  • Pharmacovigilance regulations, clinical trial ADR reporting requirements n Drug surveillance in countries outside Europe
  • Drug surveillance in countries outside Europe
  • Post-marketing surveillance: observational cohort studies
  • An overview of signal detection and risk management plans (RMPs)

This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.

Who should attend?

Anybody involved and interested in the daily practice of pharmacovigilance, including pharmaceutical physicians and those working in:

  • Drug safety
  • Adverse reaction monitoring
  • R&D
  • Regulatory affairs
  • Registration

Reviews of IPI's Pharmacovigilance training course

All of the speakers were absolutely great, the talks were very interesting, informative and on a high level.

Jan 31 2024

Yulia Buberman
PVG , Kamada LTD

Jan 31 2024

Excellent speakers and very experienced.

Joanna Jakubowicz
Deputy QPPV, Ovelle

Dec 14 2022

I was hoping to gain better knowledge and better understanding of how PV works, and by attending this course I believe I have achieve that.

Christian Boateng
PV Scientist, Norgine Ltd

Dec 14 2022

Content: very good. Presentation: Good Speakers: very good

Beatriz Blanco-Rodriguez
Global Regulatory Affairs & Pharmacovigilance , Life Molecular Imaging

Dec 14 2022


Laetitia Boldini
Specialist Regulatory Affairs Junior, Lallemand

Dec 6 2021

I hoped to get an overview on all aspects of PV - my expectations were totally met

Bettina Bannert
Doctor, Universitätsspital Basel/ Department Klinische Forschung

Dec 6 2021

It was a very good webinar - I would use management forum again for other training.

Ellie Sutcliffe
PV Administrator/Associate, Rosemont Pharmaceuticals

Jun 21 2021

Very informative and great 3 days.

Paul Byrne
Deputy QPPV, Nelsons

Dec 2 2019

I loved the course and it was amazing to be taught by people who are very experienced in the topics and be able to get their insights and hear their experiences.

Tina Tayebi
Pharmacovigilance Associate, Diamond Pharma Services

Jun 24 2019

The course was very well organised and useful. The choice of speakers was very good and balanced. Overall, I was very happy with the course.

Karl Pauls
Medical advisor, Centre for epidemiology and health research (ZEG)

Jun 24 2019

Workshop is very good because you have to USE the knowledge you gain. Interaction between speaker and attendees is very good too!

Anna Bøgelund Møller
Pharmacovigilance scientist, Larix

Jun 24 2019

The course gave overall understanding on pharmacovigilance. The presentations were clear and with helpful examples. Interaction between participants and speakers was great. All the speakers have good experiences and knowledge.

Teodora Crowe-Wijasa
Consultant Medical Safety Physician, DADA Consultancy BV

Jun 24 2019

Obviously all speakers have huge experiences within the PV processes.

Haiping Ma
Senior Safety Quality Professional, Novo Nordisk A/S

Dec 3 2018

Expert presenters with engaging and thoughtful presentations that allow plenty of time for questions and discussion. All very knowledgeable and engaging.

Sam Allen
Drug Safety Operations Medic, Mundipharma Research Ltd.

Dec 3 2018

My overall opinion is very positive, I am not disappointed at all. Speakers did a very good job - being approachable, giving examples, sharing his/her professional experiences, etc. Very knowledgeable speakers with relevant experience.

Vania Horta
Drug Safety & Information Officer , Wockhardt UK Limited

Dec 3 2018

Co-ordinators were great, material provided was concise and well presented. Time for breaks and lunches were spot on. Most of the speakers were excellent. I have 18 months experience in PV and I felt like the course was at my level. This course is not suitable for beginners.

Bhupesh Panchal
Drug Safety & Information Officer, Wockhardt UK Limited

Dec 3 2018

Amazing speakers with a wealth of knowledge and experience.

Dalal Abdulaziz
Regulatory Manager, Al Hafez Trading Est

Jun 19 2018

A greatly organised and informative course given by driven and well informed speakers.

Willem van Lierop
Drug Safety Manager, ApotheekZorg

Jun 19 2018

Exactly what we need. Very good.

Gabriel Georgescu
Regulatory Affairs Manager, Ewopharma AG

Dec 4 2017

Enjoyed the course. Although quite intense in the number of topics, it was well organized and stuck only to the important things. Would recommend and am thinking about continuing to The advanced PV one.

Marta Telebar
PV Project Specialist, Arriello s.r.o.

Dec 4 2017

The course was very useful and interesting to me personally

Darya Pospíšilová
Pharmacovigilance Project Manager, Arriello

Jun 20 2017

I was happy about the location, the presenters and the organizers for this course

Abdullah Al Dawood
QPPV and Regulatory Affairs Supervisor , Apotex Saudi Arabia

Jun 20 2017

The course was well structured and covered all important aspects of PV. Everything was presented in clear presentations with helpful examples. Interactions between participants and speakers was easy and helpful.

Birte Hofmann
Director Pharmacokinetics Expert, Bayer AG

Dec 4 2017

All the speakers are knowledgable and have good experience

Negin Goudarz
Pharmacovigilance Associate , Emas Pharma Ltd

Dec 4 2017

Very nice and informative course, very satisfied

Birgitte Wolf
Senior Safety Specialist , LEO Pharma

Jun 20 2017

Found the content delivered from the speakers very good.

Priya Cutts
Report Specialist, Procter and Gamble Technical Centres Ltd

Dec 6 2016

Well organised and the speakers were very knowledgeable

Claire McLaughlin
Drug Safety Specialist, Kyowa Kirin International

Dec 6 2016

Excellent. Very good speakers and interactions.

Susanne Mathias
Senior GCP Advisor Specialist, Novo Nordisk A/S

Dec 6 2016

Very passionate speakers

Sabrina Montante
Safety Scientist, GlaxoSmithKline

Dec 6 2016

It was very good, I had a great time

Camille Soulet
Vigilances Training Officer, Pierre Fabre

Jun 20 2016

It was a comprehensive, professional course, well organized and beneficial

Liron Weisman
Pharmacovigilance Compliance Associate, Teva Pharmaceuticals Industries Ltd

Jun 20 2016

Very nice course which provides good instruction into PV and overall picture of PV requirements/obligations

Oresta Makaruha Stegic
FDF RA manager, xellia

Dec 6 2016

High level training with great speakers, very good welcome and accommodation

Camille Soulet
Vigilances Training Officer, Pierre Fabre

Dec 6 2016

I feel this course gives a good amount of information and is presented well. The speakers are very knowledgeable

Lee Rolfe
Actavis plc

Dec 6 2016

Overall I found the course to be very informative. Not only did I learn new information, but it helped me realise how much information I have picked up through my short time working in the industry and it reinforced this knowledge. I liked that there were a number of different speakers from different backgrounds who effectively cover different aspects of the topic in depth.

Sarah Bruce
Pharmacovigilance Officer, Kyowa Kirin

Dec 6 2016

I think the course and its content were very well run and I would be happy to attend another course by Management Forum

Lee Rolfe
Actavis plc

Jun 20 2016

Informative and well-organised but quite heavy going in parts

Gemma Anthony
PV & Regulatory Administrator, Meda Pharma Ltd

United Kingdom

  • .
  • 2Health Limited
  • Actavis plc
  • Actelion Pharmaceuticals
  • ADAMAS Consulting
  • Adamas Consulting Ltd
  • Alcon Laboratories (UK) Ltd
  • Allergan UK Limited
  • Antisoma Research Ltd
  • Arrow No.7 Limited
  • Aspar Pharmaceuticals Ltd
  • AstraZeneca
  • AstraZeneca R&D Charnwood
  • AstraZeneca UK Ltd
  • Auden McKenzie Group
  • Avecia Biotechnology Ltd
  • Bell's Healthcare
  • Bells Healthcare
  • Biogen IDEC Ltd
  • British American Tobacco Ltd
  • Brown & Burk UK Ltd
  • BTG International Ltd
  • Cambridge Healthcare Supplies Ltd
  • Celgene Europe Ltd
  • Cephalon (UK) Limited
  • Cephalon UK Ltd
  • Chiesi Limited
  • Chiesi Ltd
  • Chiltern International
  • Chugai Pharma Europe Ltd
  • City University, London
  • Clinigen
  • Cmed Clinical Research Services Ltd
  • Cycle Pharmaceuticals
  • Daiichi Sankyo UK Ltd
  • Dannika Consulting Ltd
  • Department of Health
  • Diamond Pharma Services
  • Eisai Europe Limited
  • Eisai Limited
  • Eisai Ltd
  • Eli Lilly & Co Ltd
  • Eli Lilly & Company Limited/Elanco Animal Health
  • Emas Pharma Ltd
  • Epic Database Research Company Ltd
  • European Medicines Agency
  • EUSA Pharma
  • Ewopharma International s.r.o.
  • Ferring Pharmaceuticals Ltd
  • Genus Pharmaceuticals Ltd
  • GlaxoSmithKline
  • GlaxoSmithKline Services Unlimited
  • GMClinical
  • GW Pharmaceuticals
  • GW Pharmaceuticals Limited
  • GW Pharmaceuticals Ltd
  • Harefield Pharmacovigilance Ltd
  • Hospira UK Limited
  • Hospira UK Ltd
  • Idis Limited
  • Immunocore Limited
  • Immunocore Ltd
  • IMS Health UK
  • Ipsen Biopharm Ltd
  • Janssen-Cilag Ltd
  • Jazz Pharmaceuticals
  • JensonR+ Limited
  • Kyowa Kirin
  • Kyowa Kirin International
  • M&A Pharmachem
  • Marlborough Pharmaceuticals Ltd
  • Martindale Pharma
  • Meda Pharma Ltd
  • Meda Pharmaceuticals Limited
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medtronic Ltd
  • Merck Pharmaceuticals Limited
  • Merck Sharp & Dohme Ltd
  • Mitsubishi Tanabe Pharma Europe
  • Mundi Pharma Int Ltd
  • Mundipharma Research Ltd
  • Mundipharma Research Ltd.
  • NDA Regulatory Science Ltd
  • Nelsons
  • Nicoventures Ltd
  • Norgine Ltd
  • Novartis Pharmaceuticals UK Ltd
  • Novatis Animal Health UK Ltd
  • Novo Nordisk Ltd
  • Octapharma Ltd
  • Oracle Corporation UK Ltd
  • Oxford Biomedica
  • PAGB (The Proprietary Association of Great Britain)
  • PAION UK Ltd
  • Parexel International Ltd
  • Perkin Elmer LAS (UK) Ltd
  • Piramal Healthcare Ltd
  • Procter & Gamble
  • Procter & Gamble Technical Centres Ltd
  • Procter and Gamble Technical Centres Ltd
  • ProductLife Group
  • ProductLife Limited
  • Profile Pharma
  • Public Health England
  • Pure Drug Safety Ltd
  • QA Pharmaceutical Services
  • Reckitt Benckiser
  • Regional QC Laboratory
  • Roche Products Ltd
  • Rosemont Pharmaceuticals
  • Rosemont Pharmaceuticals Limited
  • Rosemont Pharmaceuticals Ltd
  • Rosemount Pharmaceutical
  • Rotapharm Ltd
  • Scottish National Blood Transfusion Service
  • SEQ Limited
  • Servier R&D Ltd
  • Shire Pharmaceutical Ltd
  • South Devon Healthcare NHSTrust
  • Stiefel Laboratories
  • Stiefel Labs (UK) Limited
  • Strakan Pharmaceuticals, Prostrakan Limited
  • Sunovion Pharmaceuticals Europe Ltd
  • Swedish Orphan Biovitrum
  • Takeda Development Centre Europe Ltd
  • Takeda UK Limited
  • Teva UK Limited
  • The Mentholatum Company
  • Thornton & Ross Ltd
  • Toray Industries Inc
  • Torbay and South Devon NHS Trust
  • Trac Services Ltd
  • UCB Celltech
  • UCB Pharma Limited
  • Unilever
  • United Therapeutics Europe Ltd
  • University of Bradford
  • University of London
  • Veriton Pharma
  • Warner Chilcott Pharmaceuticals UK Ltd
  • WBA Global Sourcing
  • Weleda
  • Winthrop Pharmaceuticals UK Ltd
  • Wise Pharmacies Limited
  • Wockhardt UK Limited
  • Wyeth Europa Ltd
  • Wyeth Pharmaceuticals
  • Zanza Laboratories Ltd


  • Actelion Pharmaceutical Ltd
  • Actelion Pharmaceuticals Ltd
  • Actelion Pharmaceuticals Ltd.
  • F. Hoffmann La Roche
  • F. Hoffmann-La Roche
  • F. Hoffmann-La Roche Ltd
  • Geistlich Pharma
  • Ginsana SA
  • Helsinn Healthcare S.A.
  • IBSA Institut Biochimique SA
  • Nestle Research Centre
  • NNIT A/S
  • Novartis Consumer Health SA
  • Novartis International AG
  • Novartis Pharma AG
  • Roche
  • Roche Pharma (Schweiz) AG
  • Roche Pharma (Switzerland) Ltd
  • SkyePharma AG
  • Speedel
  • Swiss Tropical Institute
  • United Biosource Corporation
  • Universitätsspital Basel/ Department Klinische Forschung
  • Vifor SA


  • ABBOTT GmbH & Co KG
  • Abbott Laboratories GmbH
  • Abbott Products GmbH
  • Bavarian Nordic GmbH
  • Bayer AG
  • Bayer Pharma AG
  • Centre for epidemiology and health research (ZEG)
  • Dr Willmar Schwabe GmbH & Co
  • Fresenius Kabi Deutschland GmbH
  • Life Molecular Imaging
  • Linde
  • Medac GmbH
  • Merck KGaA
  • Mundipharma Research GmbH & Co Kg
  • Mylan Healthcare GmbH
  • Otsuka Pharmaceutical Development and Commercialisation Europe
  • Solvay Deutschland GmbH
  • Takeda GmbH


  • Abbott Healthcare Products B.V
  • Apotheekzorg
  • ApotheekZorg Sittard
  • Astellas BV
  • Astellas Pharma Europe BV
  • Aurobindo Pharma BV
  • Bilthoven Biologicals BV
  • Celgene B.V
  • Centrafarm Pharmaceuticals BV
  • DADA Consultancy BV
  • Genzyme Europe BV
  • HAL Allergy BV Leiden
  • Julius Clinical Research
  • Leyden Delta bv
  • Merck BV
  • Merck Sharp & Dohme
  • N.V. Organon
  • Synthon Biopharmaceuticals BV


  • 4 Clinics
  • Baxter R&D Europe
  • Bristol-Myers Squibb SA
  • Colgate Palmolive Research & Development Inc
  • Colgate-Palmolive R&D
  • Glaxo Smithkline Biologicals
  • GlaxoSmithKline
  • GlaxoSmithKline Vaccines
  • Guerbet
  • Janssen Pharmaceutica NV
  • Oystershell NV
  • Sanofi-Aventis
  • SGS Belgium NV
  • SGS Belgium NV Life Science Services
  • UCB Pharma SA


  • Aeras Global TB Vaccine Foundation
  • Air Liquide Santé International
  • AnticipSante SAS
  • DBV Technologies
  • Guerbet
  • Johnson & Johnson
  • Lallemand
  • LFB Biotechnologies
  • Pierre Fabre
  • Pierre Fabre Medicament
  • Sanofi Pasteur MSD
  • Sanofi Pasteur Siege mondial
  • Sanofi-Synthelabo Groupe
  • Schering-Plough


  • Ferring Pharmaceuticals
  • Ferring Pharmaceuticals A/S
  • Ferring Pharmaceuticals.
  • H. Lundbeck A/S
  • Larix
  • LEO Pharma
  • Leo Pharma A/S
  • Novo Nordish A/S
  • Novo Nordisk
  • Novo Nordisk A/S


  • Athlone Laboratories
  • Ferring Ireland Ltd
  • Irotec Laboratories
  • Kora Healthcare
  • NorthStar Healthcare Ltd
  • Ovelle
  • Pfizer Limited
  • Pinewood Healthcare Limited
  • Pinewood Healthcare Ltd.


  • Faes Farma S.A.
  • Faes Farma SA
  • Grupo Ferrer Internacional SA
  • Grupo Ferrer Internaional S.A.
  • Laboratorios Almirall S A
  • Laboratorios Leti SL Unipersonal
  • Reig Jofre Group


  • Gsap Medlogic
  • Kamada Ltd
  • Maccabi Health Services
  • Maccabi Healthcare Services
  • Teva Pharm Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Teva Pharmaceuticals Industries Ltd


  • AstraZeneca
  • Astrazeneca R&D
  • Clean Chemical Sweden AB
  • Q-Med AB
  • Sanofi-aventis AB
  • Scientific Solutions Scandinavia AB
  • SOBI


  • Agency for Medicinal Products and Medical Devices of Croatia
  • Europharma doo
  • Pliva Hrvatska D.O.O.
  • Providens
  • Providens Ltd
  • xellia

Czech Republic

  • Arriello
  • Arriello s.r.o.
  • Baxter Czech spol. S r.o.
  • Teva Czech Industries S R O
  • Zentiva Group AS
  • Zentiva, k.s.

United States of America

  • Abbott Laboratories
  • Aeras Global TB Vaccine Foundation
  • Jazz Pharmaceuticals Inc
  • Next Generation Clinical Research
  • Santen

Saudi Arabia

  • Al Faisaliah Medical Systems
  • Apotex Saudi Arabia
  • Saudi Food and Drug Authority
  • SFH


  • Baxter Innovations GmbH
  • Boehringer Ingelheim RCV GmbH & Co KG
  • Boehringer Ingelheim Regional Center Vienna GmbH & Co KG
  • Octapharma Pharmazeutika Produktionsges.m.b.H.


  • AstraZeneca SPA
  • Chiesi Farmaceutici SPA
  • Recordati
  • Warner Chilcott Italy Srl


  • Amgen LLC
  • Evrokontakt Plus
  • Roche Moscow Ltd.
  • Voyage Tour LLC


  • Ewopharma AG
  • Romastru Trading Srl
  • Worwag Pharma GmbH & Co. KG


  • Blood Transfusion Centre of Slovenia
  • LEK Pharmaceuticals d.d.
  • Medis, d.o.o


  • ApoPharma Inc
  • Aspreva Pharmaceuticals Corporation


  • Orion Corporation Orion Pharma


  • Acorus Calamus
  • UAB Sicor Biotech


  • Pronova BioPharma Norge AS
  • Targovax ASA


  • Medicines and Medical Devices Agency of Serbia
  • Poslovni centar Hemofarm

Slovak Republic

  • Ewopharma International s.r.o
  • Ewopharma International, s.r.o.


  • O & D Pharma
  • Schering-Plough CE AG


  • Promed




  • Seqirus


  • Natura Inovacao Tecnologia de Produtos Ltda.




  • Vitale-XD Ltd


  • AstraZeneca SA


  • DR Reddys Laboratories Ltd


  • Cobel Darou


  • United Nations


  • Clinipace Wordwide

Korea, Democratic People's Republic Of

  • Archigen Biotech Limited

Korea, Republic Of

  • Korea Food & Drug Administration


  • Al Hafez Trading Est


  • Balkan Pharmaceuticals


  • Taiwan Drug Relief Foundation


  • Novo Nordisk

Run Pharmacovigilance Bespoke training for your team

3 days

Typical duration

Pricing from:

  • GBP 1,200
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online


We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Training expert

+44 (0)20 7749 4749